Search

April 3, 2019
| Presentation
Hill N. S., et al.
INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH). ISHLT 39th Annual Meeting & Scientific Sessions
Orlando, FL
June 28, 2018
| Poster
Roscigno R, et al.
Phase 1 Safety and Pharmacokinetic Study of Inhaled LIQ861, a New Dry Powder Formulation of Treprostinil. In: PHA’s International PH Conference
Orlando, FL
March 11, 2018
| Poster
Anderson S, et al.
LIQ865A Produces a Slow Controlled Release of Bupivacaine after Subcutaneous Dosing in Rats and Minipigs. In: SOT Annual Meeting
San Antonio, TX
March 11, 2018
| Poster
Wilson SD, et al.
LIQ865A, a Slow Release Microparticle Formulation of Bupivacaine, is Well-Tolerated and Does Not Interfere with Wound Healing after Subcutaneous Dosing in Rats and Minipigs. In: SOT Annual Meeting
San Antonio, TX